Literature DB >> 3722376

The multiple acyl-coenzyme A dehydrogenation disorders, glutaric aciduria type II and ethylmalonic-adipic aciduria. Mitochondrial fatty acid oxidation, acyl-coenzyme A dehydrogenase, and electron transfer flavoprotein activities in fibroblasts.

B A Amendt, W J Rhead.   

Abstract

The multiple acyl-coenzyme A (CoA) dehydrogenation disorders (MAD) include severe (S) and mild (M) variants, glutaric aciduria type II (MAD:S) and ethylmalonic-adipic aciduria (MAD:M). Intact MAD:M mitochondria oxidized [1-14C]octanoate, [1-14C]palmityl-CoA, and [1,5-14C]glutarate at 20-46% of control levels; MAD:S mitochondria oxidized these three substrates at 0.4-18% of control levels. In MAD:M mitochondria, acyl-CoA dehydrogenase (ADH) activities were similar to control, whereas MAD:S ADH activities ranged from 38% to 73% of control. Electron transfer flavoprotein (ETF) activities in five MAD:M cell lines ranged from 29 to 51% of control (P less than 0.01); ETF deficiency was the primary enzymatic defect in two MAD:M lines. In four MAD:S patients, ETF activities ranged from 3% to 6% of control (P less than 0.001); flavin adenine dinucleotide addition increased residual ETF activity from 4% to 21% of control in a single MAD:S line (P less than 0.01). Three MAD:S patients had ETF activities ranging from 33 to 53% of control; other investigators found deficient ETF-dehydrogenase activity in these MAD:S and three of our MAD:M cell lines.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3722376      PMCID: PMC329551          DOI: 10.1172/JCI112553

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

1.  The purification and some properties of electron transfer flavoprotein and general fatty acyl coenzyme A dehydrogenase from pig liver mitochondria.

Authors:  C L Hall; H Kamin
Journal:  J Biol Chem       Date:  1975-05-10       Impact factor: 5.157

2.  Novel tritium release assays for isovaleryl-CoA and butyryl-CoA dehydrogenases.

Authors:  W J Rhead; C L Hall; K Tanaka
Journal:  J Biol Chem       Date:  1981-02-25       Impact factor: 5.157

3.  Glutaric aciduria type II: report on a previously undescribed metabolic disorder.

Authors:  H Przyrembel; U Wendel; K Becker; H J Bremer; L Bruinvis; D Ketting; S K Wadman
Journal:  Clin Chim Acta       Date:  1976-01-16       Impact factor: 3.786

4.  Demonstration of a specific mitochondrial isovaleryl-CoA dehydrogenase deficiency in fibroblasts from patients with isovaleric acidemia.

Authors:  W J Rhead; K Tanaka
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

5.  Multiple acyl-CoA dehydrogenase deficiency (glutaric aciduria type II) with transient hypersarcosinemia and sarcosinuria; possible inherited deficiency of an electron transfer flavoprotein.

Authors:  S I Goodman; E R McCabe; P V Fennessey; J W Mace
Journal:  Pediatr Res       Date:  1980-01       Impact factor: 3.756

6.  Biochemical studies in a patient with defects in the metabolism of acyl-CoA and sarcosine: another possible case of glutaric aciduria type II.

Authors:  N Gregersen; S Kølvraa; K Rasmussen; E Christensen; N J Brandt; F Ebbesen; F H Hansen
Journal:  J Inherit Metab Dis       Date:  1980       Impact factor: 4.982

7.  Ethylmalonic-adipic aciduria. In vivo and in vitro studies indicating deficiency of activities of multiple acyl-CoA dehydrogenases.

Authors:  S Mantagos; M Genel; K Tanaka
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808

8.  Glutaric aciduria type II: in vitro studies on substrate oxidation, acyl-CoA dehydrogenases, and electron-transferring flavoprotein in cultured skin fibroblasts.

Authors:  W Rhead; S Mantagos; K Tanaka
Journal:  Pediatr Res       Date:  1980-12       Impact factor: 3.756

9.  Riboflavin-responsive ethylmalonic-adipic aciduria.

Authors:  A Green; T G Marshall; M J Bennett; R G Gray; R J Pollitt
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

10.  Recurrent hypoglycemia associated with glutaric aciduria type II in an adult.

Authors:  G Dusheiko; M C Kew; B I Joffe; J R Lewin; S Mantagos; K Tanaka
Journal:  N Engl J Med       Date:  1979-12-27       Impact factor: 91.245

View more
  16 in total

1.  Antenatal expression of multiple acyl-CoA dehydrogenase deficiency.

Authors:  C Vianey-Saban; R Bouvier; P Cochat; A Buenerd; P Divry; R Dumoulin; M P Cordier
Journal:  J Inherit Metab Dis       Date:  2000-06       Impact factor: 4.982

2.  Measurement of the acyl-CoA intermediates of beta-oxidation by h.p.l.c. with on-line radiochemical and photodiode-array detection. Application to the study of [U-14C]hexadecanoate oxidation by intact rat liver mitochondria.

Authors:  N J Watmough; D M Turnbull; H S Sherratt; K Bartlett
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

3.  Genetic deficiency of short-chain acyl-coenzyme A dehydrogenase in cultured fibroblasts from a patient with muscle carnitine deficiency and severe skeletal muscle weakness.

Authors:  P M Coates; D E Hale; G Finocchiaro; K Tanaka; S C Winter
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

4.  The importance of recognizing secondary carnitine deficiency in organic acidaemias: case report in glutaric acidaemia type II.

Authors:  H Mandel; D Africk; M Blitzer; E Shapira
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

Review 5.  The inborn errors of mitochondrial fatty acid oxidation.

Authors:  C Vianey-Liaud; P Divry; N Gregersen; M Mathieu
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

6.  Brown-Vialetto-Van Laere and Fazio Londe syndromes: defects of riboflavin transport with biochemical similarities to multiple acyl-CoA dehydrogenation defects (MADD).

Authors:  Michael J Bennett
Journal:  J Inherit Metab Dis       Date:  2012-09-14       Impact factor: 4.982

7.  Complementation analysis of fatty acid oxidation disorders.

Authors:  A Moon; W J Rhead
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

Review 8.  The biochemical basis of mitochondrial diseases.

Authors:  H R Scholte
Journal:  J Bioenerg Biomembr       Date:  1988-04       Impact factor: 2.945

9.  C7orf10 encodes succinate-hydroxymethylglutarate CoA-transferase, the enzyme that converts glutarate to glutaryl-CoA.

Authors:  Simon Marlaire; Emile Van Schaftingen; Maria Veiga-da-Cunha
Journal:  J Inherit Metab Dis       Date:  2013-07-27       Impact factor: 4.982

10.  CypD(-/-) hearts have altered levels of proteins involved in Krebs cycle, branch chain amino acid degradation and pyruvate metabolism.

Authors:  Sara Menazza; Renee Wong; Tiffany Nguyen; Guanghui Wang; Marjan Gucek; Elizabeth Murphy
Journal:  J Mol Cell Cardiol       Date:  2012-12-19       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.